These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24078620)

  • 21. Patient mobility in the European Union: pushing for EU internal health market.
    Lang IG
    Med Law; 2009 Dec; 28(4):661-71. PubMed ID: 20157977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Health status of mothers and children in Poland compared to other European Union countries on the basis of EURO-PERISTAT indicators].
    Szamotulska K
    Med Wieku Rozwoj; 2010; 14(2):113-28. PubMed ID: 20919462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inequalities in medicine use in Central Eastern Europe: an empirical investigation of socioeconomic determinants in eight countries.
    Vogler S; Österle A; Mayer S
    Int J Equity Health; 2015 Nov; 14():124. PubMed ID: 26541292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between tobacco control policies and population at high risk of lung cancer in the European Union.
    González-Marrón A; Martín-Sánchez JC; Miró Q; Matilla-Santander N; Cartanyà-Hueso À; Mucci L; Martínez-Sánchez JM
    Environ Res; 2019 Dec; 179(Pt A):108594. PubMed ID: 31541906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving cancer control in the European Union: conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007.
    Gouveia J; Coleman MP; Haward R; Zanetti R; Hakama M; Borras JM; Primic-Zakelj M; de Koning HJ; Travado L
    Eur J Cancer; 2008 Jul; 44(10):1457-62. PubMed ID: 18325756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends of cervical cancer mortality in the member states of the European Union.
    Arbyn M; Raifu AO; Weiderpass E; Bray F; Anttila A
    Eur J Cancer; 2009 Oct; 45(15):2640-8. PubMed ID: 19695864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unemployment, public-sector health-care spending and breast cancer mortality in the European Union: 1990-2009.
    Maruthappu M; Watkins JA; Waqar M; Williams C; Ali R; Atun R; Faiz O; Zeltner T
    Eur J Public Health; 2015 Apr; 25(2):330-5. PubMed ID: 25236370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Global Health Policies of the EU and its Member States: A Common Vision?
    Steurs L; Van de Pas R; Delputte S; Orbie J
    Int J Health Policy Manag; 2018 May; 7(5):433-442. PubMed ID: 29764107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Do we understand Brussels? Risks and opportunities for the Netherlands' health care policy within the European Union].
    de Man FH; Straetmans G; Annard W
    Ned Tijdschr Geneeskd; 2001 Mar; 145(12):590-3. PubMed ID: 11294001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in cancer mortality in the European Union and accession countries, 1980-2000.
    Levi F; Lucchini F; Negri E; Zatonski W; Boyle P; La Vecchia C
    Ann Oncol; 2004 Sep; 15(9):1425-31. PubMed ID: 15319250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of data availability on population health indicators at the regional level across the European Union.
    Costa C; Freitas Â; Stefanik I; Krafft T; Pilot E; Morrison J; Santana P
    Popul Health Metr; 2019 Aug; 17(1):11. PubMed ID: 31391120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transposition and implementation of EU rare disease policy in Eastern Europe.
    Pejcic AV; Iskrov G; Raycheva R; Stefanov R; Jakovljevic MM
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):557-566. PubMed ID: 28975845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic burden of malignant blood disorders across Europe: a population-based cost analysis.
    Burns R; Leal J; Sullivan R; Luengo-Fernandez R
    Lancet Haematol; 2016 Aug; 3(8):e362-70. PubMed ID: 27476787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis and evaluation of the effectiveness of demographic policies in EU countries (2009-2010).
    Pierrakos G; Balourdos D; Soulis S; Sarris M; Pateras J; Skolarikos P; Farfaras A
    World Health Popul; 2014; 15(1):31-43. PubMed ID: 24702764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corruption In Health Care Systems: Trends In Informal Payments Across Twenty-Eight EU Countries, 2013-19.
    Dallera G; Palladino R; Filippidis FT
    Health Aff (Millwood); 2022 Sep; 41(9):1342-1352. PubMed ID: 36067438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do the determinants of the COVID-19 mortality rate differ between European Union countries with different adult population pyramids?
    Cifuentes-Faura J
    Public Health; 2021 Sep; 198():82-84. PubMed ID: 34365110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    Fears R; Kaufmann S; Ter Meulen V; Zumla A;
    Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health indicators in Europe: availability and data needs.
    Kilpeläinen K; Tuomi-Nikula A; Thelen J; Gissler M; Sihvonen AP; Kramers P; Aromaa A
    Eur J Public Health; 2012 Oct; 22(5):716-21. PubMed ID: 22294775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical carcinoma in the European Union: an update on disease burden, screening program state of activation, and coverage as of March 2014.
    Altobelli E; Lattanzi A
    Int J Gynecol Cancer; 2015 Mar; 25(3):474-83. PubMed ID: 25695550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in corpus uteri cancer mortality in member states of the European Union.
    Weiderpass E; Antoine J; Bray FI; Oh JK; Arbyn M
    Eur J Cancer; 2014 Jun; 50(9):1675-84. PubMed ID: 24656568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.